Skip to product information
Attorney Kim's Bio Study Diary
Attorney Kim's Bio Study Diary
Description
Book Introduction
Every time a new government comes into power, it promises to 'foster bio', but it keeps fading away.
A few years ago, it was said that “the bio industry is overflowing with money,” but now many bio companies are worried about their survival.
But no industry can become a trend from the start.
The atmosphere becomes ripe only after going through times when one's heart swells with hope and is frustrated with despair.
Companies and people who don't give up until then will be able to ride the huge upward trend.


Health, food, and the environment are the issues that people most directly encounter in their lives.
Automobiles, electronics and communications come next.
Bio is divided into red bio, green bio, and white bio.
Bio's interest lies in how to live in a healthy and good environment, using less energy, and eating healthy foods.


So, it is up to us, 'ordinary people', not researchers, industry practitioners, or professional investors, to take an interest in bio.
Isn't it the same for everyone in the world to eat healthy, good food, live in a good environment, and use clean energy?
When they learn about bio, bio will become a leading industry.


This book is an expression of my efforts as an 'ordinary person' to learn about bio.
Although I'm just beginning my journey into the world of bio, I hope other "ordinary people" will also become interested in what bio can do, and soon understand its meaning from their own perspectives, whether it's health, food, the environment, or even careers and investments.

index
Preface 4
The Meaning of the Bio Industry 15
Telemedicine 19
Drug Repurposing 22
Comparison of SC and IV formulations 24
Organoid artificial organ 26
OTOF gene 29
NRDO Strategy 31
T cell 34
CDK7 inhibitor 36
Atopic dermatitis 38
Immunity (Philip Detmer) 41
Exosome 43
Insomnia Treatment 45
Vaccine 47
Aptamer ADC 49
Phospholipid bilayer 51
KRAS protein 53
NK cell therapy 56
Biofoundry 61
CAR-TIL, CAR-MIL 65
Infoboss 69
The Life of Protein (Kazuhiro Nagata) 71
Why Bats Don't Get Sick 73
A seemingly joke app that cures illness? 75
Biopharmaceutical Revolution (Lee Seong-gyu) 77
Botulinum toxin 79
Herceptin biosimilar 81
Irid BMS 83
Alto Neuroscience 85
mRNA tail 88
90 Key Players of Immunity
Stem Cell Therapy and Hair Loss 93
Parkinson's disease 95
TOP1 97
AppClone zCAR-T 99
Central Dogma 101
Understanding Bioscience (Kim Seong-min) 104
Bispecific antibody 107
PARP-1 110
Dual antibody ADC 112
human papillomavirus (HPV) 114
Wegobi, a cardiovascular disease prevention drug, receives approval 117 times.
Interleukin 7 118
Maru Therapeutics 120
Space Drug Development 123
Asgardian Archaea 125
EGFR TKI 128
circular mRNA 130
Ubiquitin proteasome system (UPS) 132
Gene Scissors 134
Immunity Map 137
Fibroblast 139
MDSC 142
Retinal degenerative disease 144
Lipid nanoparticle (LNP) 147
Medical AI 150
Skin Organoid 153
D&D Pharmatech 155
157 "Innovative Pharmaceutical Company" Certifications Cancelled
Anctiva (bladder cancer treatment) 159
Phosphorylation reaction 161
Innovation New Drug Salon Pangyo 164
Complexity Studies 166
In vitro diagnostics market 169
JLK, Stroke Diagnosis 171
Biosimilars and Patents 173
Amendment 175 to the Unfair Competition Prevention Act
Oscotec 177
Voronoi, a compound discovery technology 179
Code Breaker (Jennifer Doudna) 183
Development of xenotransplantation products 185
Considerations Before Entering a Clinical Trial 189
Vor Biopharma, Tremcel 192
Cancer Vaccine 197
Sleep Tech 199
23andME 202
b7-h4 b7-h3 ADC 204
Claudin 18.2 206
Limkato State 208
non-opioid 210
Taiwan TBMC 212
Plant Immunity 214
Technology Export and Return 217
EMA Recommends Denial of Donanemab Approval 219
Runit Insight MMG 221
Curocel, Anvalcell lupus clinical trial 223
Biotechnology Export Gap (China and Korea) 225
Enhanced Blood Glucose Alert Device 226
Parkinson's disease treatment 'pracinezumab' 228
Forest Carbon Storage Capacity 231
Lunit and Microsoft Collaborate on Research 234
Enforcement of Voting Rights Restriction Agreements 236
Conclusion 240
GOODS SPECIFICS
- Date of issue: November 10, 2025
- Page count, weight, size: 246 pages | 128*188*20mm
- ISBN13: 9791112084835

You may also like

카테고리